Norway – Pharmaceutical products – Framework agreement for medicinal products and multi-doses for Sogndal
Kuvaus
Background and purpose Sogndal municipality wishes to enter into a framework agreement for the delivery of medicines, multi-dose and pharmacy products for the village of Sogndal. Bygdene Leikanger and Balestrand are all involved in a framework agreement through the INSS procurement cooperation. Medicine for a heimebuande vert dekka av brukaren sjølv and is not a part of the economic ramma of the agreement. The costs involved in packing a multi-dose to a home-bound host paid for by the municipality. The framework agreement does not cover medical consumables, as the municipality has a framework agreement for this. Description of customer The contract is for Sogndal in Sogndal municipality. All references to "Sogndal" debts the village of Sogndal, not the municipality as cheering. Sogndal has approx. 9,000 inhabitants. Sogndal has approx. 46 heildøgnsplassar institution, 300 user of heimeteneste, 260 heimebuande, which has medicine administered by the municipality, 165 uses with multidose.
CPV-koodit
Asiakirjat & lähetys
Contains data from Tenders Electronic Daily (TED), © European Union, ted.europa.eu — CC BY 4.0.
Aiheeseen liittyvät hankinnat
Norway – Pharmaceutical products – Medicines and multi-dose Narvik kommune - Framework agreement
Harstad KommuneNorjaPharmaceutical productsMedicinal products for dermatology and the musculo-skeletal systemPharmaceutical articlesEräpäivä 26 päivässäJulkaistu 03.11.2026
Norway – Medical equipments – Linac to Sørlandet Hospital
SYKEHUSINNKJØP HFNorjaMedical equipmentsLinear acceleratorsEi eräpäivää annettuJulkaistu 03.11.2026
Norway – Medical equipments – Copy of PCR instrument
SYKEHUSINNKJØP HFNorjaMedical equipmentsEräpäivä 30 päivässäJulkaistu 03.11.2026
Norway – Sterilisation, disinfection and hygiene devices – Low temperature steriliser for the sterile centre in Helse Bergen.
SYKEHUSINNKJØP HFNorjaSterilisation, disinfection and hygiene devicesEräpäivä 33 päivässäJulkaistu 03.11.2026